COVID 6 Months On; Intensivist Shortages; Denier Learns the Hard Way

Six months after the first “novel coronavirus” infection (not yet named COVID-19) was diagnosed in the U.S., the unofficial U.S. COVID-19 toll reached 4,294,770 cases and 148,056 deaths as of 8:00 a.m. ET Tuesday. That’s up 60,630 cases and 1,121 deaths, respectively, from yesterday.

The World Health Organization said Tuesday not to expect a second wave of infections and deaths — because there is only one big wave with no seasonal respite. (Reuters)
HHS signed a $265-million contract with Fujifilm in Texas to lock down manufacturing capacity for COVID-19 vaccines. But some Democrats say the total amount needed is more like $40 billion. (STAT)

Senate Republicans proposed another $1 trillion in COVID relief, including a Paycheck Protection Program extension, $105 billion for schools, and billions more for public health initiatives including testing and vaccine development. (Axios)

Louisiana and Mississippi are slated to run out of intensivists to treat non-COVID patients by week’s end; Texas and Arizona already have, according to a report out of George Washington University.

Google employees will not return to company offices until July 2021 at the earliest. (TechCrunch)

Across party lines, Americans are reassured about individual steps taken to reduce COVID-19 spread, like mask wearing. It’s the unpredictability of the country as a whole that is causing stress, according to an American Psychological Association poll.

The U.S. can “virtually eliminate the virus” at any time, said former CMS chief Andy Slavitt, who laid out the plan in a Twitter novella.

The Miami Marlins postponed their home opener against the Baltimore Orioles last night after 14 players and coaches tested positive for the virus. (ESPN)

The Mayo Clinic scored first place in the U.S. News & World Report’s pre-pandemic evaluation of 4,500 hospitals.

The first boy with muscular dystrophy to receive an experimental gene therapy is not just walking, but running 5 years after his treatment.